登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C20H28I3N3O9
化学文摘社编号:
分子量:
835.16
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
产品名称
Iodixanol Related Compound D, United States Pharmacopeia (USP) Reference Standard
SMILES string
Ic1c(c(c(c(c1C(=O)NCC(O)CO)I)C(=O)NCC(O)CO)I)N(CC(O)COC)C(=O)C
InChI
1S/C20H28I3N3O9/c1-9(29)26(5-12(32)8-35-2)18-16(22)13(19(33)24-3-10(30)6-27)15(21)14(17(18)23)20(34)25-4-11(31)7-28/h10-12,27-28,30-32H,3-8H2,1-2H3,(H,24,33)(H,25,34)
InChI key
IUNJANQVIJDFTQ-UHFFFAOYSA-N
grade
pharmaceutical primary standard
API family
iodixanol
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
正在寻找类似产品? 访问 产品对比指南
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Application
Iodixanol Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
Also, for use with USP monographs such as:
- Iodixanol Injection
- Iodixanol
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Nikolaos L Kelekis et al.
Clinical imaging, 28(2), 124-127 (2004-03-31)
Confluent hepatic fibrosis (CHF) is usually a feature of advanced cirrhosis, while occurrence in early stage compensated cirrhosis is uncommon. We report the imaging findings of masslike CHF in a patient with previously unsuspected compensated alcoholic cirrhosis. The combination of
Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque).
E Laffitte et al.
The British journal of dermatology, 150(2), 376-378 (2004-03-05)
G Jung et al.
Journal of computer assisted tomography, 24(5), 783-787 (2000-10-25)
To evaluate the diagnostic value of MR imaging in abdominal lymphoma staging, in comparison with that of the established spiral CT, within the context of a prospective study. 50 patients with non-Hodgkin (n = 27) and Hodgkin lymphoma (n =
Markus Selzner et al.
Annals of surgery, 240(6), 1027-1034 (2004-12-01)
To compare the diagnostic value of contrast-enhanced CT (ceCT) and 2-[18-F]-fluoro-2-deoxyglucose-PET/CT in patients with metastatic colorectal cancer to the liver. Despite preoperative evaluation with ceCT, the tumor load in patients with metastatic colorectal cancer to the liver is often underestimated.
H U Kauczor et al.
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 174(3), 357-362 (2002-03-09)
Determination of the intrahepatic distribution volume of two contrast media (CM) by CT-guided application in an ex-vivo and an in-vivo model (pig liver). In pig livers ex-vivo and in-vivo, 131 CT-guided injections of two different CM (Imagopaque(R), Visipaque(R)) were performed
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持